Objectives: The purpose of this study was to analyze the effect of beta blockade on outcome
in patients with heart failure (HF) and atrial fibrillation (AF). Background: Beta-blockers are …

Atrial fibrillation is increasingly encountered in patients with heart failure. Both diseases
have seen tremendous rises in incidence in recent years. In general, the treatment of atrial …

Aims Pulsed field ablation (PFA) is a novel atrial fibrillation (AF) ablation modality that has
demonstrated preferential tissue ablation, including no oesophageal damage, in first-in …

Heart failure with preserved ejection fraction (HFpEF) and atrial fibrillation (AF) are very
common conditions, particularly in the elderly. However, the mechanisms underlying the two …

Background: Pulsed field ablation is a novel nonthermal cardiac ablation modality using
ultra-rapid electrical pulses to cause cell death by a mechanism of irreversible …

Aims Oesophageal fistula represents a rare but dreadful complication of atrial fibrillation
catheter ablation. Data on its incidence, management, and outcome are sparse. Methods …

Aims It is unknown whether lenient rate control is an acceptable strategy in patients with AF
and heart failure. We evaluated differences in outcome in patients with AF and heart failure …

Supraventricular tachycardias (SVTs) are a major cause of morbidity in adults with
congenital heart disease (CHD). Few data exist on safety and efficacy of antiarrhythmic …

Aims Beneficial effects of beta‐blockade remain unclear in heart failure patients who have
atrial fibrillation (AF), especially in the elderly. We evaluated the effect of nebivolol on …

Aims Pulsed field ablation (PFA) is a new, non-thermal ablation modality for pulmonary vein
(PV) isolation in patients with atrial fibrillation (AF). The multi-centre EUropean Real World …